Artelo Biosciences (ARTL) Return on Capital Employed [ROCE] (2015 - 2026)
Artelo Biosciences (ARTL) reported Return on Capital Employed [ROCE] of -639.59% for Q1 2026, up 120.34 percentage points from -759.92% a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2024, Artelo Biosciences posted Return on Capital Employed [ROCE] of -142.40%, down 78.09 percentage points from FY2023.
- Return on Capital Employed [ROCE] has a five-year change of -9.68 percentage points (FY2019 to FY2024).
- By year, Return on Capital Employed [ROCE] came in at -64.30% in FY2023 (-20.23 pp), -44.08% in FY2022 (+4.43 pp), -48.50% in FY2021 and -95.08% in FY2020 (+37.63 pp).
- The Q1 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
- Year over year, Return on Capital Employed [ROCE] gained in 1 of the last five quarters, with an average year-over-year change of -170.99 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2026 (a gain of 120.34 percentage points); the low point was Q1 2025 (a drop of 666.76 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | -137.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -137.79% |
| Mar 31, 2026 | -639.59% |
| Mar 31, 2025 | -759.92% |
| Dec 31, 2024 | -243.86% |
| Sep 30, 2024 | -135.57% |
| Jun 30, 2024 | -130.42% |
| Mar 31, 2024 | -93.16% |
| Dec 31, 2023 | -76.50% |
| Sep 30, 2023 | -66.59% |
| Jun 30, 2023 | -58.25% |
| Mar 31, 2023 | -57.09% |
| Dec 31, 2022 | -50.37% |
| Sep 30, 2022 | -40.83% |
| Jun 30, 2022 | -36.84% |
| Mar 31, 2022 | -31.94% |
| Nov 30, 2021 | -40.21% |
| May 31, 2021 | -52.79% |
| Feb 28, 2021 | -48.45% |
| Nov 30, 2020 | -73.94% |
| Aug 31, 2020 | -136.47% |
API Access
Artelo Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();